The application relates generally to medical equipment, and in particular relates to medical equipment that aids in preventing a person who has or may potentially have a contagious respiratory condition from spreading the condition into his or her environment and, in some embodiments, simultaneously providing therapeutic treatment to the person.
The rapid spread of the infectious COVID-19 coronavirus disease has been deemed a worldwide pandemic. As is presently known, the COVID-19 virus causes respiratory illness with symptoms such as a fever, a cough, and in some cases, difficulty in breathing, and is spread primarily through contact with aerosol droplets expelled by an infected person when they cough, sneeze, or even merely breathe, and/or when a previously uninfected person touches a surface or object that has the virus on it (e.g., due to droplet-aerosol spread), and then touches their own eyes, nose, or mouth. Also as is presently known, in some cases, infected persons may not exhibit any physical symptoms associated with COVID-19 and feel entirely healthy, but may nonetheless may spread the virus to others.
COVID-19 and other highly transmissible respiratory illnesses have the potential to quickly overwhelm hospital capacity and available medical resources. For example, as COVID-19 can rapidly evolve to acute hypoxemia and respiratory distress syndrome-type illness, numerous mechanical ventilators may be needed to treat infected patients. Other medical resources which are needed to treat patients who have or who are suspected to have COVID-19 or other highly transmissible respiratory illnesses include negative air pressure rooms in which the patients may be sequestered to aid in mitigating droplet-aerosol spread to others in the hospital or medical facility, and personal protective equipment or PPE (such as gloves, face masks, gowns, drapes, goggles, shields, etc.) worn by health care providers to protect them from contracting the illness from the patients who are under their care. These and other critical medical resources may quickly become limited and in short supply (if at all) when the illness(es) spread rapidly throughout a population, e.g., during a pandemic.
For patients who have trouble breathing, but whose condition is not critical enough to warrant the use of a mechanical ventilator, health care providers may outfit them with a heated high flow nasal cannula (HFNC). HFNCs may be utilized for such types of patients, as well as for patients who suffer from hypoxic respiratory failure and other types of conditions resulting from respiratory illnesses such as COVID-19. HFNCs may deliver a heated, humid mixture of ambient air and oxygen (or, in some cases, pure oxygen) to patients at flows up to 60-100 liters per minute. Use of HFNCs may aid in liberating patients from mechanical ventilator use as their conditions improve, and may more generally free up supplies of mechanical ventilators for use by patients that are in more critical condition, as less critical patients may be serviced by HFNCs.
However, the use of HFNCs may present various risks and challenges when utilized by patients who have or who are suspected of having COVID-19 or other highly transmissible respiratory illnesses. For example, the high flow rate delivered by HFNCs may cause or increase the aerosolization of viruses and/or of bacteria residing in the patient, and in particular, when the patient coughs. The impact of such droplet-aerosol spread is further exacerbated by the limited supply of negative pressure rooms during pandemics, and is not easily mitigated by having patients wear face masks, as patients utilizing HFNCs typically do not tolerate mask coverings well. For example, use of an HFNC may cause masks to fog up and provide an uncomfortably humid environment for the patient. Further, many systems prohibit the use of nasal cannula flows above 6 liters per minute (e.g., at least due to potential aerosolization of viruses and/or bacteria from the respiratory system of the user at flow levels greater than 6 liters per minute), which results in patients being intubated earlier than would otherwise be needed, and in some cases, needlessly. Similar risks and challenges exist when patients are administered bronchodilator aerosols and other therapeutic treatments while utilizing HFNCs.
Embodiments of the Personal Respiratory Isolation System (PRIS) disclosed herein provide a personal isolation system for individual use by a patient who has or who is suspected of having a transmissible respiratory illness, such as COVID-19. Generally speaking, the embodiments of the PRIS provide a personal, negative pressure environment for the user that reduces contamination and potential spread of viral and/or bacterial pathogens that are expelled and/or exhaled by the user into the environment in which the user is located. Further, some embodiments of the PRIS may also simultaneously provide the user with therapeutic and/or medicinal treatments, and/or may simultaneously provide protection for an immunocompromised user.
The PRIS includes an enclosure which is particularly designed and configured to contain a negative pressure environment into which the user breathes, and thereby isolating respiratory fluid (e.g., air and/or liquid) that is exhaled and/or expelled by the user (e.g., via the user's nose and/or mouth) and preventing the user's fluid outflow from being dispersed directly into the user's surroundings. The respiratory fluid outflow of the user may include bacterial and/or viral pathogens, aerosol particles produced from aerosolizing or potentially aerosolizing procedures and/or therapies to which the user has been subjected, and the like.
The enclosure of the PRIS may include a fluid output port coupled to a negative pressure source (e.g., a vacuum, a reverse fan and motor combination, etc.) that is disposed outside of the PRIS' enclosure. During operations, the negative pressure source may draw ambient air into the interior of the enclosure, e.g., via one or more openings in the enclosure that allow ambient air to enter. Such openings may be inherently provided by one or more components of the PRIS (such as via the aperture via which the user enters into the enclosure, via the folds of a flexible drape that is included in the PRIS, etc.), and/or such openings may be passively provided by the PRIS, e.g., via general cracks and/or gaps that are present between unsealed components of the PRIS. In some embodiments, the enclosure of the PRIS may additionally or alternatively include an explicit inflow port via which ambient air is allowed to enter into the enclosure. For example, an explicit, ambient air inflow port may be disposed in a rigid portion of the PRIS. As such, the intentionally unsealed or “leaky” nature of the PRIS allows the movement of ambient air into the enclosure's interior, which not only allows the user to breathe air that not circulated or re-circulated, but also may cool and/or dehumidify the interior of the enclosure (such as when the user is wearing a heated respiratory device) for the user's comfort and ease of use.
At any rate, in addition to drawing ambient air into the interior of the enclosure via one or more ambient air openings, the negative pressure source may also (e.g., simultaneously) draw air that is disposed within the interior of the enclosure (which includes both drawn ambient air and the user's fluid outflow) through the fluid output port. As such, the PRIS allows the user's fluid outflow to be collected in a controlled manner. The collected fluid outflow may be filtered to collect pathogenic particles and/or may be treated with a pathogen-impairing technique (such as ultra-violet radiation, high temperatures, autoclaving, etc.) prior to venting the outflow into the environment. In some embodiments, the interior air that is drawn through the fluid output port may be collected into a container for safe, biohazard processing or disposal.
In some embodiments, the PRIS may additionally deliver ambient air, oxygen, aerosolized medicine, and/or other therapeutic treatments to the user as the user is disposed within the personal, negative pressure environment provided by the PRIS. Generally, these therapeutic treatments may be directly administered to the user within the negative pressure environment via a direct, positive air pressure mechanism or technique, such as via a heated, high flow nasal cannula, a continuous positive airway pressure (CPAP) device, an oxygen face mask that delivers oxygen and/or aerosol treatments, and the like. In some use cases, though, the user may wear, in conjunction with the PRIS, some other type of respiratory device that does not provide positive airway pressure, such as a passive face mask.
In some embodiments, the PRIS may maintain the negative pressure level within the interior of the enclosure at a desired pressure level. For example, the amount and/or the flow rate at which interior air is drawn through the fluid output port may be detected and controlled to maintain the desired pressure level. Additionally or alternatively, in embodiments in which direct therapeutic treatments are administered to the user within the negative pressure environment, the amount and/or the flow rate at which such treatments are administered may be detected and controlled to maintain the desired pressure level within the enclosure's interior. Still additionally or alternatively, in embodiments, the amount and/or the flow rate at which ambient air is drawn into the interior of the enclosure may be detected and controlled to maintain the desired pressure level within the enclosure's interior.
In accordance with a first example embodiment, a personal respiratory isolation system (PRIS) includes an enclosure that includes an aperture configured to receive only a portion of a body of a user into an interior of the enclosure so that a nose and a mouth of the user are contained within the enclosure. Additionally, the enclosure includes one or more rigid portions, at least a part of which is disposed to shield the nose and the mouth of the user from an environment in which the user is located while the nose and the mouth of the user are contained within the enclosure, the at least the part of the one or more rigid portions which is disposed to shield the nose and the mouth of the user being a shield. The shield may be substantially rigid or flexible, for example. The enclosure further includes an opening via which ambient air enters into the interior of the enclosure, and a flow output port that is coupled to a negative pressure source disposed outside of or external to the enclosure. The negative pressure source is operable to draw air that is disposed within the interior of the enclosure through the flow output port to thereby provide or produce a negative pressure within the interior of the enclosure, where the drawn interior air including fluid that has been at least one of exhaled or expelled by the user.
In accordance with a second example embodiment, a method of controlling a pressure of a personal respiratory isolation system (PRIS) that is being utilized by a user is disclosed. The PRIS whose pressure is controlled by the method includes an enclosure, and the enclosure includes an aperture via which only a portion of a body of the user has been received into an interior of the enclosure so that a nose and a mouth of the user are contained within the enclosure. Additionally, the enclosure includes a particular portion shielding the nose and the mouth of the user from an environment in which the user is located, and an opening via which ambient air is allowed to enter into the interior of the enclosure. The enclosure further includes a flow output port through which air that is disposed within the interior of the enclosure is being drawn by a negative pressure source. The negative pressure source is coupled to the flow output port and is disposed outside of (e.g., external to) the enclosure, and the interior air that is being drawn through the fluid output port includes (i) fluid that has been at least one of exhaled or expelled by the user, and (ii) ambient air that has been drawn, by the negative pressure source, into the interior of the enclosure via the opening.
The method includes, at a controller communicatively connected to one or more control elements associated with the PRIS, receiving, at the controller via one or more communication interfaces, an indication of a signal generated by a sensor, where the signal is indicative of at least one of: an amount or a flow rate of the air that is being drawn by the negative pressure source from the interior of the enclosure through the flow output port. The method also includes determining, by the controller and based on the indication of the signal, one or more adjustments to the one or more control elements; and transmitting, by the controller via the one or more communication interfaces, respective indications of the one or more adjustments to the one or more control elements, thereby causing the one or more control elements to control, in accordance with the one or more adjustments, the at least one of the amount or the flow rate of the interior air that is being drawn through the flow output port, thereby maintaining a desired level of negative pressure within the interior of the enclosure.
Although the following text discloses a detailed description of example methods, apparatus and/or articles of manufacture, it should be understood that the legal scope of the property right is defined by the words of the claims set forth at the end of this patent. Accordingly, the following detailed description is to be construed as examples only and does not describe every possible example, as describing every possible example would be impractical, if not impossible. Numerous alternative examples could be implemented, using either current technology or technology developed after the filing date of this patent. It is envisioned that such alternative examples would still fall within the scope of the claims.
The one or more rigid portions 108 of the enclosure 105 include a physical barrier 108b that shields the user's nose and mouth (and in some implementations, such as illustrated in
In
In
In the embodiment 100, at least due to the one or more flexible portions 110, the enclosure 105 may not be entirely sealed to the surrounding environment while the user 102 is utilizing the PRIS 100. Ambient air may be allowed to enter the interior of the enclosure 105 via one or more opening(s) 115 which, in
As shown in
In some embodiments, in concert with creating the negative pressure environment surrounding the user in the interior of the enclosure 105, a fluid such as oxygen, therapeutics, and/or medicine may be delivered from an external fluid source 125 (not directly visible in
In some embodiments, the amount and/or the flow rate of interior air that is drawn by the negative pressure source 120 through the flow output port 118 may be adjusted and/or controlled (e.g., via one or more corresponding control valves coupled to the flow output port 118, the hose or tube 122, and/or the negative pressure source 120) to maintain a desired pressure within the enclosure 105. Typically, the desired pressure level within the enclosure 105 is some level of negative pressure; however, in some implementations, the desired pressure level within the enclosure 105 may be zero pressure. In embodiments in which the enclosure 105 also includes the flow inlet 128 via which the tubing 130 is received into the interior of the enclosure 105 to deliver desired fluid to the user 102, the amount and/or flow rate of fluid that is delivered directly to the user 102 via the tubing 130 may be independently adjusted and/or controlled (e.g., via one or more corresponding control valves coupled to the device 132, the tubing 130, and/or the external fluid source 125) to maintain the desired pressure within the enclosure 105. In some embodiments of the PRIS, the amount and/or flow rate of fluid that is delivered directly to the user 102 via the tubing 130 is adjusted and/or controlled in conjunction with the adjustment and/or control of the amount and/or flow rate of the interior air that is drawn through the flow output port 118 to thereby maintain the desired pressure within the enclosure 105.
During use of the PRIS 100, the air disposed within the interior of the enclosure 105 (which includes both drawn ambient air and fluid outflow that is exhaled and/or expelled by the user 102) may be drawn by the external pressure source through the flow output port 118 of the enclosure 118 for eventual venting into the environment surrounding the user 102 and the PRIS 100. As such, to protect the user's surroundings from contamination and spread of pathogens and/or therapeutic particles, the flow output port 118, the hose or tube 122, and/or the external pressure source 120 may include one or more filters (e.g., a HEPA filter, a medical grade filter, an active carbon filter, and/or other suitable types of filters, not visible in
As additionally shown in
In some embodiments, the interior face of the shield 108a may be coated with one or more anti-fogging coatings to help minimize an amount of fogging within the interior of the enclosure 105, e.g., when using an HFNC 132 or other heated device in conjunction with the PRIS 100. Additionally or alternatively, the shield 108a itself may be comprised of or manufactured from anti-fogging materials, e.g., anti-fogging glass, plastic, or the like. Nonetheless, in prototypes of the PRIS 100 in which the shield 108a was not treated with any anti-fogging coating and was not manufactured from anti-fogging materials, tests demonstrated that the negative pressure environment created by the negative pressure source 120 was sufficient to clear any fogging generated by the HFNC 132 within the interior of the enclosure 105, both when the shield 108a was in an open position as well as when the shield 108a was in a closed position, and even when the HFNC 132 was delivering heated fluids up to a rate of 60-100 liters per minute. Further, during the testing of the prototypes, no fog leaked out of the interior of the enclosure 105 into the surrounding environment, even when the shield 108a was in an open position.
Of course, other embodiments of a Personal Respiratory Isolation System are possible. Generally, each embodiment may typically include an enclosure having an aperture via which only a portion of a user's body is received so that the user's nose and mouth are contained within the interior of the enclosure. The enclosure need not encircle the user's head, such as in the embodiments 100 and 200, so long as the enclosure includes a shield portion disposed to shield the user's nose and mouth from the user's surrounding environment. Further, the enclosure may be configured (e.g., in structure and in shape) to have sufficient integrity to maintain a negative pressure environment within its enclosure. Additionally, the enclosure may have a flow output port via which air disposed within the interior of the enclosure is drawn by a negative pressure source for eventual collection or venting into the user's surroundings. As such, embodiments of the PRIS in which the drawn interior air is eventually vented into the environment may include a filter and/or the drawn interior air may be subjected to a pathogen-impairing process prior to a remainder of the drawn interior air into user's surroundings, e.g., in manners such as previously described.
Embodiments of the PRIS need not include rigid or substantially portions. That is, in some embodiments, a majority of the enclosure may comprise flexible materials and/or portions, with the only possible rigid component being one that causes the aperture to remain sufficiently open to receive the user's head or other body part(s) into the enclosure's interior. In an embodiment, a PRIS may be implemented using a tent-like structure that comprises one or more substantially-rigid portions and/or flexible portions which are supported by a frame that may cover (only) a portion of the patient, e.g., while the patient is in a prone position. For example, the patient's torso and head may be disposed within the interior of the PRIS. At least some portions of the tent-like structure may be transparent. Advantageously, the structure or form factor of the tent allows the patient to wear other types of health care devices (e.g., monitors, intravenous and/or other types of catheters, etc.) while being in an isolated respiratory environment. In such embodiments, the PRIS may include one or more flaps which may be opened to allow health care workers to provide direct aid or treatments to the patient. While the flaps are in the open position, the draw of the negative pressure source may be increased to mitigate the spread of any pathogens while the flaps are in the open position, and may return back to the steady-state draw level after the flaps have been closed.
Indeed, in some embodiments of the tent-like PRIS, the tent structure may include different chambers, each of which is serviced by a different fluid outflow port. The different chambers may be drawn to the same level of pressure, or to different levels of pressure, if desired. For example, a respiratory chamber may enclose the user's head while a separate chamber may enclose the user's torso. As such, health care workers who are performing medical procedures on the torso of the user may be further protected from pathogen aerosolization generated by the user.
In other embodiments, the PRIS need not include flexible portions. For example, the enclosure of the PRIS may consist of only rigid portions, in embodiments.
In some embodiments, the PRIS may be a sealed environment. For example, after the head or other body part of the user has been received into the interior of the enclosure, the aperture may be sealed around the user. In these embodiments, ambient air may be allowed to enter into the enclosure's interior via an ambient air port that is disposed within a particular rigid portion or a particular flexible portion of the enclosure. The ambient air port may also be sealed from the environment, and an amount or a flow rate of ambient air drawn through the ambient air port (e.g., via the negative pressure source) may be adjusted and/or controlled (e.g., either individually, and/or in conjunction with other control valves) to maintain the pressure inside the enclosure at a desired level.
In some embodiments, the entire PRIS may be disposable, e.g., may be single use. In other embodiments, at least a portion of the rigid portion(s) of the PRIS's enclosure may be disposable or single use, and/or at least a portion of the flexible portion(s) of the PRIS's enclosure may be disposable or single use. In some embodiments, the entire PRIS may be made of materials which are able to be sterilized using any known medical-grade sterilization process (e.g., high temperatures, ultra-violet rays, cleaning agents, etc.) and re-used. In other embodiments, at least a portion of the rigid portion(s) of the PRIS' enclosure may be sterilizable and re-used, and/or at least a portion of the flexible portion(s) of the PRIS's enclosure may be sterilizable and re-used.
Other aspects and/or features which may be included in various embodiments of the PRIS may include one or more of the following:
Of course, other aspects may be additionally or alternatively included in embodiments of the Personal Respiratory Isolation System described herein.
Turning now to
The method 300 may be performed by a controller that is communicatively connected to one or more control elements associated with the PR IS. The controller may be an industrial process controller or other suitable computing device having one or more communication interfaces that communicatively connect the controller to other devices, such as sensors, computing devices, and the like. The PRIS may include an enclosure, and the enclosure may include an aperture via which only a portion of a body of the user has been received into an interior of the enclosure so that a nose and a mouth of the user are contained within the enclosure. The enclosure may also include a substantially rigid or flexible portion shielding the nose and the mouth of the user from an environment in which the user is located, an opening via which ambient air enters into the interior of the enclosure, and a flow output port through which air that is disposed within the interior of the enclosure is being drawn by a negative pressure source. Typically, the negative pressure source is coupled to the flow output port and disposed outside of the enclosure, and the interior air includes (i) fluid that has been at least one of exhaled or expelled by the user, and (ii) ambient air that has been drawn, by the negative pressure source, into the interior of the enclosure via the opening.
At a block 302, the method 300 includes receiving, at the controller via one or more communication interfaces, an indication of a signal generated by a sensor that is associated with the PRIS. That is, the sensor may detect or sense some condition associated with operation of the PRIS. For example, the received indication of the sensor signal may be indicative of an amount or a flow rate of the interior air that is being drawn by the negative pressure source through the flow output port. The received indication of the sensor signal may be received at the controller directly from the sensor or via an intermediate device or memory, for example. In an embodiment, at the block 302, the method 300 may include receiving indications of multiple sensor signals. For example, the block 302 may include receiving indications of the amount or the flow rate of the fluid that is being delivered from the external fluid source to the user, the amount or the flow rate of ambient air that is being drawn into the interior of the enclosure via the ambient air opening(s) of the enclosure, a sensed level of pressure within the interior of the enclosure, a sensed temperature and/or humidity level within the interior of the enclosure, and/or other sensed conditions associated with the operations of the PRIS.
At a block 305, the method 300 includes determining, by the controller and based on the indication of the sensor signal(s), one or more adjustments to the one or more control elements associated with the PRIS. For example, the controller may execute a control loop or control routine (which, in an implementation, may comprise a set of computer-executable instructions that are stored on one or more memories of the controller and that are executable by one or more processors of the controller) to determine the one or more adjustments. The sensor signal may be an input process variable to the control loop, the desired pressure level that is to be maintained within the interior of the enclosure may be a setpoint utilized by the control loop, and the control loop may subsequently generate indications of the one or more adjustments as an output, for example, as one or more control signals. Of course, in other implementations, the adjustments may be determined by some other type of function and/or logic sequence, and/or indications of the one or more adjustments may include other types of signals or messages.
At a block 308, the method 300 includes transmitting, by the controller via the one or more communication interfaces, indications of the one or more adjustments to the one or more control elements, thereby causing the one or more control elements to control, in accordance with the one or more adjustments, an amount and/or a rate of an inflow and/or an outflow associated with the PRIS, and thereby maintaining a desired level of negative pressure within the interior of the enclosure. The one or more control elements may control, for example, the amount or the flow rate of the interior air that is being drawn through the flow output port, the amount or the flow rate of the fluid that is being delivered from the external fluid source to the user, and/or the amount or the flow rate of ambient air that is being drawn into the interior of the enclosure via the ambient air opening(s) of the enclosure. For example, the one or more control elements may correspond to control valves that are respectively coupled to the external fluid source, the tubing that delivers fluid from the external fluid source into the interior of the PRIS's enclosure, the positive airway pressure device worn by the user, the negative pressure source, the hose or tube interconnecting the negative pressure source with the flow output port of the PRIS's enclosure, the flow output port, an ambient air port, and/or other components that are included and/or associated with the PRIS. The indications of the one or more adjustments may be the one or more control signals generated by the control loop of block 305, or may be other types of indications.
In some embodiments, a user instruction or command initiates an execution of the method 300. In some embodiments, the controller automatically initiates an execution of the method 300, e.g., upon expiration of a timer, upon an occurrence of a triggering event such as an alarm or an alert, a changed sensor value, etc., and/or repeatedly over some interval of time.
In some embodiments, the controller includes or is communicatively connected to, e.g., via the one or more communication interfaces, a user interface via which commands and/or instructions may be received from an operator. For example, an operator of the PRIS may enter instructions via a user interface of a portable computing device, a website, or a portal. Operator instructions may include, for example, an instruction to modify the desired level of negative pressure; an instruction to at least one of add, delete, or modify one or more alarm settings or alert settings associated with the PRIS; an instruction to modify the control loop and therefore how the one or more adjustments are determined at the block 305; an instruction to transmit, via the one or more communication interfaces to at least one of one or more user interfaces and/or other computing devices, data corresponding to operations of the PRIS associated with the user; and/or other instructions related to controlling the pressure within the interior of the enclosure of the PRIS. For example, data corresponding to operations of the PRIS associated with the user may be transmitted to another computing device that administers electronic medical records.
The user interface via which the instructions are received from the operator and/or the recipient user interfaces and/or computing devices may be communicatively connected with the controller via one or more wired and/or wireless links, for example. In some implementations, the user interface via which the instructions are received from the operator and/or the recipient user interfaces and/or computing devices may be communicatively connected via one or more networks.
As illustrated in
The computing device 402 may include a program memory 408 storing one or more sets of computer-readable and/or computer-executable instructions, e.g., instructions 410a-410c, a processor 412 (e.g., a controller, a microcontroller, a microprocessor, etc.), a random-access memory (RAM) 415, and an input/output (I/O) circuit 418, all of which may be interconnected via an address/data bus 420. The program memory 408 may comprise one or more tangible, non-transitory computer-readable storage media and/or devices, and the computer-readable and/or computer-executable instructions 410a-410c stored thereon, when executed by the processor 412, may cause the computing device 402 to perform control of one or more components of the PRIS.
In doing so, the computing device 402 may access one or more data or memory storage devices 422 at which data corresponding to the system 400 and to the PRIS may be stored. The one or more data storage devices 422 may comprise, for example, one or more memory devices, a data bank, cloud data storage, and/or one or more other suitable data storage devices. Indeed, the one or more data storage devices 422 may include one physical device, or the one or more data or memory storage devices 422 may include more than one physical device. The one or more data storage devices 422, though, may logically appear as a single data storage device irrespective of the number of physical devices included therein. Accordingly, for ease of discussion only and not for limitation purposes, the data storage device 422 is referred to herein using the singular tense.
In one embodiment (not shown), at least one of the one or more data storage devices 422 may be included in the computing device 402, and the processor 412 of the computing device 402 (or the instructions 410 executed by the processor 412) may access the one or more data storage devices 422 via a link comprising a read or write command, function, application programming interface, plug-in, operation, instruction, and/or similar (which may, in turn, also be provided by the computing device 402, an embodiment).
In the present embodiment illustrated in
Additionally or alternatively, the system 400 may include and the network 432 may communicatively connect one or more computing devices that host one or more websites, portals, server applications, remote applications, customer-facing processes, etc. (reference 435). For example, the website/portal computing device 435 may host a website, portal, or other remote application via which a user may enter thresholds, control routine modifications, alarm or alert settings, and the like, e.g., via the computing device 402.
As depicted in
It is noted that while in
With particular regard to the computing device 402, in addition to the instructions 410, the program memory 408 may store thereon further computer-readable or computer-executable instructions 455 that further particularly configure the computing device 402 and that may be executed in conjunction with PRIS control applications. For example, the other instructions 455 may execute to allow a user to produce reports, integrate PRIS information with a patient's electronic medical records, and the like.
In some embodiments, at least a portion of the other instructions 455 may be integral with at least a portion of the instructions 410.
Further, with regard to the computing device 402, while the instructions 410 are shown as three different blocks 410a, 410b, 410c in
Still further, it should be appreciated that although only one processor 412 is shown, the computing device 402 may include multiple processors 412. Additionally, although the I/O circuit 418 is shown as a single block, it should be appreciated that the I/O circuit 418 may include a number of different types of I/O circuits. Similarly, the memory of the computing device 402 may include multiple RAMs 415 and/or multiple program memories 408. Further, while the instructions 410, and/or the other instructions 455 are shown being stored in the program memory 408, any or all of the instructions 410, 455 may additionally or alternatively be partially or entirely stored in the RAM 415 and/or other suitable local memory (not shown).
The RAM(s) 415 and/or program memories 408 may be implemented as semiconductor memories, magnetically readable memories, chemically or biologically readable memories, and/or optically readable memories, and/or may utilize any suitable memory technology or technologies. The computing device 402 may also be operatively connected to the network 432 via the link 430 and the I/O circuit 418, in some embodiments.
Thus, in view of the above, the Personal Respiratory Isolation System (PRIS) provides multiple, significant benefits and advantages. Significantly, the PRIS provides a personalized, negative pressure environment for a wearer that has been diagnosed with or is suspected of having a transmissible respiratory illness, such as (but not limited to) COVID-19, thereby reducing contamination of the environment in which the wearer or use is located, as well as reducing the potential spread of viral and/or bacterial pathogens which may be present in the user's fluid outflow. Advantageously, the PRIS is compatible with and functions in conjunction with direct, positive airway pressure devices utilized by the wearer or user, even when such devices cause the user to more often exhale or expel outflow fluid (e.g., aerosolization), such as when the devices operate in a heated manner (e.g., high flow nasal cannulas) and/or when such devices are not well tolerated by the user. Additionally, due to at least the ambient air drawn into the interior of the PRIS's enclosure, the interior of the enclosure is cooled for the user's comfort. Further, the PRIS allows for user mobility as the PRIS may travel with the user to procedures, advanced imaging labs, the restroom, and the like. Still further, embodiments of the PRIS which include lift-able shields allow the user to eat and drink while simultaneously reducing the risks of contaminating surrounding environments.
Moreover, use of the PRIS within medical settings such as hospitals may alleviate the number of patients who need to be held in negative pressure rooms and/or emergency rooms. For example, patients who have or are suspected of having transmissible respiratory illnesses may don respective PRISs within waiting rooms or other areas in which the general population is located instead of taking up valuable beds within negative pressure rooms and/or emergency rooms, even when such patients are not wearing and/or are not in need of therapeutic respiratory devices such as HFNCs, oxygen masks, etc. Further, in embodiments of the PRIS in which therapeutic treatments are delivered to wearer (e.g., via the patient wearing a therapeutic respiratory device while utilizing the PRIS), the use of such PRISs is particularly advantageous for patients who need respiratory treatment, but are able to receive therapeutic benefits without the use of a mechanical ventilator, thereby freeing up mechanical ventilators for other patients with more serious respiratory conditions, as well as minimizing needless and/or premature use of more invasive procedures (e.g., intubation). Accordingly, use of the PRIS not only reduces the risk of contamination and pathogen spread, but also alleviates the shortages of limited, critical medical resources such as Personal Protective Equipment that is utilized by health care workers, space in negative pressure rooms, and mechanical ventilators, to name a few, and further, allows a certain population of patients to be less invasively treated.
In
As depicted in
The one or more outflow sensors 540a-540c are respectively positioned and configured to detect one or more characteristics of a fluid outflow generated by the user 502. The user's fluid outflow may include fluid outflow that is exhaled by the user 502, and optionally may include fluid outflow that is otherwise expelled by the user 502. For example, as illustrated in
The one or more characteristics detected by the user outflow sensors 542a-542c may include, for example, a volume of user fluid outflow, a rate of user fluid outflow, and/or respective levels of various components included in the user fluid outflow, such as oxygen levels, levels of various aerosolized therapeutics and/or medicines that have been used to treat the user 502, pathogens (such as viruses and/or bacteria), volatile organic compounds, volatile inorganic compounds, and/or other characteristics.
The outflow user interface 545 may include a visual display, auditory signals (such as auditory steady state indicators, alerts, alarms, etc.), and/or any other type of desired user interface. Generally, the outflow user interface 545 may present thereon respective indications of the one or more characteristics detected by the one or more outflow sensors 540a-540c, such as numerical values, graphical representations, statuses, alerts, alarms, and the like. In some embodiments, the outflow user interface 545 may be included in a monitoring device that continuously monitors the one or more characteristics of the user fluid outflow over time, e.g., based on periodic and/or updated signals generated by the user outflow sensors 540a-540c.
In some embodiments, the outflow user interface 545 may be included in and/or communicatively connected to one or more computing devices (not shown in
Advantageously, the information indicative of the one or more characteristics detected by the one or more user outflow sensors 540a-540c that is presented on the outflow user interface 545 may be utilized to determine a diagnosis of a medical condition of the user 502 and/or to determine a treatment plan for the user 502. For example, local medical personnel may observe changing values of user outflow characteristics on an outflow user interface 545 of a locally disposed monitoring device, and may take mitigating and/or emergency actions when necessary. In another example, information indicative of the user's outflow characteristics may be aggregated with that of other users, and may be analyzed to discover new information at a population level, such as characteristics of disease progression, treatment efficacies, and the like.
Throughout this specification, plural instances may implement components, operations, or structures described as a single instance. Although individual operations of one or more methods are illustrated and described as separate operations, one or more of the individual operations may be performed concurrently, and nothing requires that the operations be performed in the order illustrated. Structures and functionality presented as separate components in example configurations may be implemented as a combined structure or component. Similarly, structures and functionality presented as a single component may be implemented as separate components. These and other variations, modifications, additions, and improvements fall within the scope of the subject matter herein.
Additionally, certain embodiments are described herein as including logic or a number of routines, subroutines, applications, or instructions. These may constitute either software (e.g., code embodied on a non-transitory, machine-readable medium) or hardware. In hardware, the routines, etc., are tangible units capable of performing certain operations and may be configured or arranged in a certain manner. In example embodiments, one or more computer systems (e.g., a standalone, client or server computer system) or one or more hardware modules of a computer system (e.g., a processor or a group of processors) may be configured by software (e.g., an application or application portion) as a hardware module that operates to perform certain operations as described herein.
In various embodiments, a hardware module may be implemented mechanically or electronically. For example, a hardware module may comprise dedicated circuitry or logic that is permanently configured (e.g., as a special-purpose processor, such as a field programmable gate array (FPGA) or an application-specific integrated circuit (ASIC) to perform certain operations. A hardware module may also comprise programmable logic or circuitry (e.g., as encompassed within a general-purpose processor or other programmable processor) that is temporarily configured by software to perform certain operations. It will be appreciated that the decision to implement a hardware module mechanically, in dedicated and permanently configured circuitry, or in temporarily configured circuitry (e.g., configured by software) may be driven by cost and time considerations.
Accordingly, the term “hardware module” should be understood to encompass a tangible entity, be that an entity that is physically constructed, permanently configured (e.g., hardwired), or temporarily configured (e.g., programmed) to operate in a certain manner or to perform certain operations described herein. Considering embodiments in which hardware modules are temporarily configured (e.g., programmed), each of the hardware modules need not be configured or instantiated at any one instance in time. For example, where the hardware modules comprise a general-purpose processor configured using software, the general-purpose processor may be configured as respective different hardware modules at different times. Software may accordingly configure a processor, for example, to constitute a particular hardware module at one instance of time and to constitute a different hardware module at a different instance of time.
Hardware modules can provide information to, and receive information from, other hardware modules. Accordingly, the described hardware modules may be regarded as being communicatively coupled. Where multiple of such hardware modules exist contemporaneously, communications may be achieved through signal transmission (e.g., over appropriate circuits and buses) that connect the hardware modules. In embodiments in which multiple hardware modules are configured or instantiated at different times, communications between such hardware modules may be achieved, for example, through the storage and retrieval of information in memory structures to which the multiple hardware modules have access. For example, one hardware module may perform an operation and store the output of that operation in a memory device to which it is communicatively coupled. A further hardware module may then, at a later time, access the memory device to retrieve and process the stored output. Hardware modules may also initiate communications with input or output devices, and can operate on a resource (e.g., a collection of information).
The various operations of example methods described herein may be performed, at least partially, by one or more processors that are temporarily configured (e.g., by software) or permanently configured to perform the relevant operations. Whether temporarily or permanently configured, such processors may constitute processor-implemented modules that operate to perform one or more operations or functions. The modules referred to herein may, in some example embodiments, comprise processor-implemented modules.
Similarly, the methods or routines described herein may be at least partially processor-implemented. For example, at least some of the operations of a method may be performed by one or more processors or processor-implemented hardware modules. The performance of certain of the operations may be distributed among the one or more processors, not only residing within a single machine, but deployed across a number of machines. In some example embodiments, the processor or processors may be located in a single location (e.g., within a home environment, an office environment or as a server farm), while in other embodiments the processors may be distributed across a number of locations.
The performance of certain of the operations may be distributed among the one or more processors, not only residing within a single machine, but deployed across a number of machines. In some example embodiments, the one or more processors or processor-implemented modules may be located in a single geographic location (e.g., within a home environment, an office environment, or a server farm). In other example embodiments, the one or more processors or processor-implemented modules may be distributed across a number of geographic locations.
Unless specifically stated otherwise, discussions herein using words such as “processing,” “computing,” “calculating,” “determining,” “presenting,” “displaying,” or the like may refer to actions or processes of a machine (e.g., a computer) that manipulates or transforms data represented as physical (e.g., electronic, magnetic, or optical) quantities within one or more memories (e.g., volatile memory, non-volatile memory, or a combination thereof), registers, or other machine components that receive, store, transmit, or display information.
As used herein any reference to “one embodiment” or “an embodiment” means that a particular element, feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. The appearances of the phrase “in one embodiment” in various places in the specification are not necessarily all referring to the same embodiment.
Some embodiments may be described using the expression “coupled” and “connected” along with their derivatives. For example, some embodiments may be described using the term “coupled” to indicate that two or more elements are in direct physical or electrical contact. The term “coupled,” however, may also mean that two or more elements are not in direct contact with each other, but yet still co-operate or interact with each other. The embodiments are not limited in this context.
Those of ordinary skill in the art will recognize that a wide variety of modifications, alterations, and combinations can be made with respect to the above described embodiments without departing from the scope of the invention, and that such modifications, alterations, and combinations are to be viewed as being within the ambit of the inventive concept.
While the present invention has been described with reference to specific examples, which are intended to be illustrative only and not to be limiting of the invention, it will be apparent to those of ordinary skill in the art that changes, additions and/or deletions may be made to the disclosed embodiments without departing from the spirit and scope of the invention.
The foregoing description is given for clearness of understanding; and no unnecessary limitations should be understood therefrom, as modifications within the scope of the invention may be apparent to those having ordinary skill in the art.
This application claims priority to and the benefit of U.S. Provisional Patent Application No. 63/010,208, filed on Apr. 15, 2020 and entitled “PERSONAL RESPIRATORY ISOLATION SYSTEM.” Additionally, this application claims priority to and the benefit of U.S. Provisional Patent Application No. 63/005,117, filed on Apr. 3, 2020 and entitled “PERSONAL RESPIRATORY ISOLATION SYSTEM,” and claims priority to and the benefit of U.S. Provisional Patent Application No. 63/002,120, filed on Mar. 30, 2020 and entitled “PERSONAL RESPIRATORY ISOLATION SYSTEM (PRIS),” the entire contents of which are incorporated by reference herein.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US21/24830 | 3/30/2021 | WO |
Number | Date | Country | |
---|---|---|---|
63002120 | Mar 2020 | US | |
63005117 | Apr 2020 | US | |
63010208 | Apr 2020 | US |